Marro becomes CFO at ObsEva

Luigi Marro will join ObsEva S.A. (NASDAQ:OBSV; SIX:OBSN) as chief transformation officer, lead the women’s reproductive health company’s commercial operational readiness initiative. Marro was previously CFO at Swiss fertility drug company Finox Biotech AG and held various roles at Serono Merck Serono over 11 years.

HiberCell Inc., which is developing therapies treating cancer relapse and metastasis, hired Jonathan Lanfear as COO. Lanfear held various senior BD roles at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) and Pfizer Inc. (NYSE:PFE). Cindy Jacobs, president and CMO at Achieve Life Sciences Inc. (NASDAQ:ACHV), joined the board...